Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patterns prevalence use vivelle® estraderm® oral premarin among women 45 years
… Medicare claims data: we estimated, in more than a million women over 70 years old who were just screened for breast cancer, what was … of stopping screening vs. continuing screening for 8 more years on breast cancer-specific mortality. We found that …
… of glucocorticoid-induced osteoporosis in post-menopausal women at high risk for fracture. Because research had shown … study. RTI-HS interviewed patients about any prior use of FORTEO®, other medications taken, and cancer risk … N, Andrews EB . Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US …
… Health Solutions, has explored the association between the use of antiepileptic drugs in pregnancy and pregnancy … Swedish Registry data. The study included over 5,000 women who used antiepileptic drugs in pregnancy and had a … we observed stronger effects at higher doses. Among infants exposed to valproic acid, we observed an …
… understand disease distribution, risk factors, treatment patterns and impact, comorbidities, burden-of-illness, other … companies reduce the uncertainty of risks to patients who use their products. …
… 18 - Saturday, October 21, 2023 Conference website 30 Years of ISOQOL: Quality of Life – making it relevant. … Estimating change score/responsiveness correlations among ordinal measures. Rockwood N, Qin S, Yarr S. Session: Oral Brief Session 202: Methodological Work Session date and …
… SGO 2023 Annual Meeting on Women's Cancer Share on: Saturday, March 25 - Tuesday, March … will be presented at the SGO 2023 Annual Meeting on Women's Cancer. Real-world evaluation of PARP inhibitor …
… “Our ethics program has continued to expand over the years and is one of the key reasons we consider RTI a great … 136 honorees were recognized spanning 22 countries and 45 industries. “Today, business leaders face their …
… Health equity is gaining increased interest and traction among pharmaceutical companies, healthcare organizations and … factors driving gaps and disparities in care and outcomes among these populations. Learning Objectives Examine the …
RWE Studies Using Primary Data Collection To meet the requirements of risk management programs, inform drug development and post-approval strategies, or answer epidemiologic questions, we can help you design and implement real-world evidence research …
… Our experience includes: Subgroup analysis Identifying patterns of treatment response Analysis of pooled data from …